The Risk of Psychiatric Disorders in Finasteride Users With Benign Prostatic Hyperplasia and Androgenetic Alopecia: A Population-Based Case-Control Study

The document critiques a study on the risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia (BPH) and androgenetic alopecia (AGA), highlighting methodological issues. It argues that the study is mislabelled as a case-control study when it is actually a retrospective cohort study, leading to potential confusion and misinterpretation of results. The study's control group, which lacks AGA, introduces confounding factors, making it difficult to attribute mental health outcomes solely to finasteride use. The critique emphasizes the importance of accurately reporting study methodologies to ensure reliable conclusions and facilitate future research.